[Problems in the establishment of indications for treatment of aortic (thoracic and abdominal) aneurysms, from a medical viewpoint (author's transl)].
D000368:Aged; D001012:Aorta, Abdominal; D001013:Aorta, Thoracic; D001014:Aortic Aneurysm / Q000188:drug therapy / Q000601:surgery*; D001019:Aortic Rupture / Q000401:mortality / Q000517:prevention & control; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D011379:Prognosis; D011433:Propranolol / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D014294:Trimethaphan / Q000627:therapeutic use
D008750:Methyldopa; D014294:Trimethaphan; D012110:Reserpine; D011433:Propranolol; D006145:Guanethidine
45. Indikatorische Problems bei Aortenaneurysmen (thorakal und abdominal) aus internistischer Sicht